Sökning: "immunosuppression"
Visar resultat 11 - 15 av 172 avhandlingar innehållade ordet immunosuppression.
11. Aspects of Tuberculosis and HIV Coinfection in Patients at Ethiopian Health Centers
Sammanfattning : HIV and tuberculosis (TB) remain the two most common infectious causes of death worldwide. During the recent decade antiretroviral treatment (ART) has become available for millions of people living with HIV (PLHIV) globally; yet more than half of PLHIV have not yet initiated ART. LÄS MER
12. Effect of thimerosal on the murine immune system : especially induction of systemic autoimmunity
Sammanfattning : The organic mercury compound ethylmercurithiosalicylate (thimerosal), an antiseptic and a preservative, has recently raised public health concern due to its presence in vaccines globally. Thimerosal dissociates in the body to thiosalicylate and ethyl mercury (EtHg), which is partly converted to inorganic mercuric mercury (Hg2+). LÄS MER
13. Posttransplant Lymphoproliferative Disorders : Studies of Epstein-Barr Virus, Regulatory T Cells and Tumor Origin
Sammanfattning : Epstein-Barr virus (EBV) infects almost all humans and establishes lifelong latency in B cells. Posttransplant lymphoproliferative disorder (PTLD) is a rare but serious complication after transplantation triggered by immunosuppression and often related to EBV infection. LÄS MER
14. Uterus transplantation: An experimental study in primates
Sammanfattning : Most causes of infertility are nowadays treatable, but for women that are infertile due to lack of, or severe malfunction of the uterus, there is as of today no available cure. Uterus transplantation (UTx) may provide a future possibility for treatment of these females with uterine factor infertility (UFI). LÄS MER
15. Opportunistic viral infection after paediatric transplantation
Sammanfattning : Background: Opportunistic viral infections can cause considerable morbidity and mortality in organ and stem cell transplanted (SCT) patients, mainly due to iatrogenic T cell dysfunction. Whereas in SCT patients, in general the immunosuppressive treatment can be discontinued after 6-12 months, for the majority of organ transplanted patients, the need for treatment is life-long. LÄS MER